Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia

To Evaluate Long- Term Safety and Efficacy of Luspatercept

NCT06875219 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

NCT06596642 ·Status: ACTIVE_NOT_RECRUITING

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT05664737 ·Status: RECRUITING ·Phase: PHASE2

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

NCT05355766 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

NCT05577312 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Long-term Follow-up Study of BRL-101 for TDT

NCT06298630 ·Status: NOT_YET_RECRUITING

A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia

NCT06302491 ·Status: RECRUITING ·Phase: PHASE2

the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

NCT05864170 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Study to Evaluate the Safety and Efficacy of Luspatercept (ACE-536) in Participants With Beta-thalassemia (A536-04/MK-6143-002)

NCT01749540 ·Status: COMPLETED ·Phase: PHASE2

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

NCT05860595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants

NCT05015920 ·Status: COMPLETED ·Phase: NA

A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia

NCT03342404 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

NCT06219239 ·Status: RECRUITING ·Phase: NA

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

NCT06073860 ·Status: RECRUITING

Long-term Clinical Study of CN128 in Thalassemia Patients

NCT04614779 ·Status: COMPLETED ·Phase: PHASE2

Study of Effects of YisuiShengxueGranules on Thalassemia

NCT01549080 ·Status: COMPLETED

Β-Thalassemia Treatment with KL003 Cell Injection

NCT06280378 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.

NCT06655662 ·Status: RECRUITING ·Phase: PHASE1

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

NCT04143724 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

NCT06024876 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major

NCT06291961 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

NCT05745532 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Safety Study for Beta Thalassemia Subjects on PTG-300

NCT04054921 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

NCT06678165 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1